| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 158.65B | 164.87B | 152.64B | 142.61B | 129.05B | 112.08B |
| Gross Profit | 57.83B | 60.38B | 56.12B | 51.78B | 46.79B | 40.02B |
| EBITDA | 25.95B | 27.49B | 25.21B | 24.18B | 20.78B | 16.19B |
| Net Income | 15.55B | 16.36B | 15.12B | 14.66B | 12.60B | 8.94B |
Balance Sheet | ||||||
| Total Assets | 150.44B | 165.06B | 147.33B | 133.33B | 121.89B | 108.19B |
| Cash, Cash Equivalents and Short-Term Investments | 5.64B | 8.36B | 62.31B | 58.03B | 53.76B | 50.15B |
| Total Debt | 2.54B | 2.22B | 1.96B | 2.10B | 1.92B | 1.96B |
| Total Liabilities | 55.58B | 64.89B | 56.14B | 50.36B | 48.02B | 42.72B |
| Stockholders Equity | 94.85B | 100.16B | 91.19B | 82.97B | 73.84B | 65.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 18.81B | 23.39B | 10.67B | 9.03B | 14.54B |
| Operating Cash Flow | 0.00 | 19.12B | 23.72B | 13.05B | 11.91B | 16.98B |
| Investing Cash Flow | 0.00 | -3.02B | -11.89B | -2.36B | -3.13B | -2.81B |
| Financing Cash Flow | 0.00 | -8.55B | -7.98B | -6.70B | -5.42B | -4.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥77.58B | 9.87 | ― | 3.28% | 5.28% | 28.90% | |
75 Outperform | ¥151.58B | 10.80 | 11.52% | 2.76% | 4.00% | 38.72% | |
74 Outperform | ¥32.69B | 58.34 | ― | ― | 29.61% | 93.16% | |
70 Outperform | ¥59.06B | 606.48 | ― | 0.28% | 8.64% | -23.20% | |
68 Neutral | ¥378.17B | 23.50 | ― | 1.48% | 8.02% | 20.57% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥93.49B | 50.39 | 4.18% | 1.97% | 19.61% | ― |